A citation-based method for searching scientific literature

David W Ellison, Olabisi E Onilude, Janet C Lindsey, Meryl E Lusher, Claire L Weston, Roger E Taylor, Andrew D Pearson, Steven C Clifford. J Clin Oncol 2005
Times Cited: 295







List of co-cited articles
809 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
61

Medulloblastoma comprises four distinct molecular variants.
Paul A Northcott, Andrey Korshunov, Hendrik Witt, Thomas Hielscher, Charles G Eberhart, Stephen Mack, Eric Bouffet, Steven C Clifford, Cynthia E Hawkins, Pim French,[...]. J Clin Oncol 2011
841
50

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Marcel Kool, Andrey Korshunov, Marc Remke, David T W Jones, Maria Schlanstein, Paul A Northcott, Yoon-Jae Cho, Jan Koster, Antoinette Schouten-van Meeteren, Dannis van Vuurden,[...]. Acta Neuropathol 2012
606
45

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Amar Gajjar, Murali Chintagumpala, David Ashley, Stewart Kellie, Larry E Kun, Thomas E Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J Krasin,[...]. Lancet Oncol 2006
587
43

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
42

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Elke Pfaff, David J H Shih, Dianna C Martin, Pedro Castelo-Branco, Berivan Baskin, Peter N Ray, Eric Bouffet,[...]. J Clin Oncol 2013
261
40

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, John Peacock, David J H Shih, Betty Luu, Livia Garzia, Jonathon Torchia, Carolina Nor, A Sorana Morrissy,[...]. Cancer Cell 2017
497
36

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
David W Ellison, James Dalton, Mehmet Kocak, Sarah Leigh Nicholson, Charles Fraga, Geoff Neale, Anna M Kenney, Dan J Brat, Arie Perry, William H Yong,[...]. Acta Neuropathol 2011
337
35

Subtypes of medulloblastoma have distinct developmental origins.
Paul Gibson, Yiai Tong, Giles Robinson, Margaret C Thompson, D Spencer Currle, Christopher Eden, Tanya A Kranenburg, Twala Hogg, Helen Poppleton, Julie Martin,[...]. Nature 2010
522
34

Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Paul A Northcott, David J H Shih, John Peacock, Livia Garzia, A Sorana Morrissy, Thomas Zichner, Adrian M Stütz, Andrey Korshunov, Jüri Reimand, Steven E Schumacher,[...]. Nature 2012
558
33

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, Sandro Santagata, Azra Ligon, Heidi Greulich, Rameen Berhoukim, Vladimir Amani, Liliana Goumnerova, Charles G Eberhart,[...]. J Clin Oncol 2011
467
33

Dissecting the genomic complexity underlying medulloblastoma.
David T W Jones, Natalie Jäger, Marcel Kool, Thomas Zichner, Barbara Hutter, Marc Sultan, Yoon-Jae Cho, Trevor J Pugh, Volker Hovestadt, Adrian M Stütz,[...]. Nature 2012
577
32

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.
Steven C Clifford, Meryl E Lusher, Janet C Lindsey, Jacqueline A Langdon, Richard J Gilbertson, Debbie Straughton, David W Ellison. Cell Cycle 2006
175
32

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Marcel Kool, David T W Jones, Natalie Jäger, Paul A Northcott, Trevor J Pugh, Volker Hovestadt, Rosario M Piro, L Adriana Esparza, Shirley L Markant, Marc Remke,[...]. Cancer Cell 2014
447
32

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Marcel Kool, Jan Koster, Jens Bunt, Nancy E Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N Caron, Jacqueline Cloos,[...]. PLoS One 2008
502
31

Medulloblastomics: the end of the beginning.
Paul A Northcott, David T W Jones, Marcel Kool, Giles W Robinson, Richard J Gilbertson, Yoon-Jae Cho, Scott L Pomeroy, Andrey Korshunov, Peter Lichter, Michael D Taylor,[...]. Nat Rev Cancer 2012
404
31

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Roger J Packer, Amar Gajjar, Gilbert Vezina, Lucy Rorke-Adams, Peter C Burger, Patricia L Robertson, Lisa Bayer, Deborah LaFond, Bernadine R Donahue, MaryAnne H Marymont,[...]. J Clin Oncol 2006
570
31

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Simon Bailey, Steven C Clifford, Francois Doz, Marcel Kool, Christelle Dufour, Gilles Vassal, Till Milde,[...]. Acta Neuropathol 2016
295
31

The whole-genome landscape of medulloblastoma subtypes.
Paul A Northcott, Ivo Buchhalter, A Sorana Morrissy, Volker Hovestadt, Joachim Weischenfeldt, Tobias Ehrenberger, Susanne Gröbner, Maia Segura-Wang, Thomas Zichner, Vasilisa A Rudneva,[...]. Nature 2017
452
31

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Margaret C Thompson, Christine Fuller, Twala L Hogg, James Dalton, David Finkelstein, Ching C Lau, Murali Chintagumpala, Adekunle Adesina, David M Ashley, Stewart J Kellie,[...]. J Clin Oncol 2006
485
30

Cytogenetic prognostication within medulloblastoma subgroups.
David J H Shih, Paul A Northcott, Marc Remke, Andrey Korshunov, Vijay Ramaswamy, Marcel Kool, Betty Luu, Yuan Yao, Xin Wang, Adrian M Dubuc,[...]. J Clin Oncol 2014
169
30

Novel mutations target distinct subgroups of medulloblastoma.
Giles Robinson, Matthew Parker, Tanya A Kranenburg, Charles Lu, Xiang Chen, Li Ding, Timothy N Phoenix, Erin Hedlund, Lei Wei, Xiaoyan Zhu,[...]. Nature 2012
554
29

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, Daniel A Pomeranz Krummel, Daniel Auclair, James Bochicchio, Mauricio O Carneiro, Scott L Carter, Kristian Cibulskis, Rachel L Erlich,[...]. Nature 2012
521
28

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone,[...]. Lancet Oncol 2017
253
27

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.
Torsten Pietsch, Rene Schmidt, Marc Remke, Andrey Korshunov, Volker Hovestadt, David T W Jones, Jörg Felsberg, Kerstin Kaulich, Tobias Goschzik, Marcel Kool,[...]. Acta Neuropathol 2014
83
31

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Claudia C Faria, Sebastien Perreault, Yoon-Jae Cho, David J Shih, Betty Luu, Adrian M Dubuc, Paul A Northcott,[...]. Lancet Oncol 2013
221
24

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
Giles W Robinson, Brent A Orr, Gang Wu, Sridharan Gururangan, Tong Lin, Ibrahim Qaddoumi, Roger J Packer, Stewart Goldman, Michael D Prados, Annick Desjardins,[...]. J Clin Oncol 2015
237
23

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.
Eric M Thompson, Thomas Hielscher, Eric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E McLendon, Darell D Bigner, Eric S Lipp, Sebastien Perreault,[...]. Lancet Oncol 2016
160
22

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
David W Ellison, Mehmet Kocak, James Dalton, Hisham Megahed, Meryl E Lusher, Sarra L Ryan, Wei Zhao, Sarah Leigh Nicholson, Roger E Taylor, Simon Bailey,[...]. J Clin Oncol 2011
193
21

Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
Birgitta Lannering, Stefan Rutkowski, Francois Doz, Barry Pizer, Göran Gustafsson, Aurora Navajas, Maura Massimino, Roel Reddingius, Martin Benesch, Christian Carrie,[...]. J Clin Oncol 2012
167
21

DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Edward C Schwalbe, Daniel Williamson, Janet C Lindsey, Dolores Hamilton, Sarra L Ryan, Hisham Megahed, Miklós Garami, Peter Hauser, Bożena Dembowska-Baginska, Danuta Perek,[...]. Acta Neuropathol 2013
89
22

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
P M Zeltzer, J M Boyett, J L Finlay, A L Albright, L B Rorke, J M Milstein, J C Allen, K R Stevens, P Stanley, H Li,[...]. J Clin Oncol 1999
505
20

Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Timothy N Phoenix, Deanna M Patmore, Scott Boop, Nidal Boulos, Megan O Jacus, Yogesh T Patel, Martine F Roussel, David Finkelstein, Liliana Goumnerova, Sebastien Perreault,[...]. Cancer Cell 2016
145
20

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Volker Hovestadt, Marc Remke, Marcel Kool, Torsten Pietsch, Paul A Northcott, Roger Fischer, Florence M G Cavalli, Vijay Ramaswamy, Marc Zapatka, Guido Reifenberger,[...]. Acta Neuropathol 2013
185
18

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
18

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Stefan Rutkowski, Udo Bode, Frank Deinlein, Holger Ottensmeier, Monika Warmuth-Metz, Niels Soerensen, Norbert Graf, Angela Emser, Torsten Pietsch, Johannes E A Wolff,[...]. N Engl J Med 2005
477
18

Prediction of central nervous system embryonal tumour outcome based on gene expression.
Scott L Pomeroy, Pablo Tamayo, Michelle Gaasenbeek, Lisa M Sturla, Michael Angelo, Margaret E McLaughlin, John Y H Kim, Liliana C Goumnerova, Peter M Black, Ching Lau,[...]. Nature 2002
18

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, Kevin Petrie, Ed C Schwalbe, Karen Barker, Jessica K R Boult, Daniel Williamson, Zai Ahmad, Albert Hallsworth,[...]. Cancer Cell 2015
123
18

Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
André O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, Carsten Friedrich, Martin Mynarek, Klaus Müller, Tobias Goschzik, Anja Zur Mühlen, Nicolas Gerber, Monika Warmuth-Metz,[...]. J Clin Oncol 2016
71
25

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
Paul A Northcott, David J H Shih, Marc Remke, Yoon-Jae Cho, Marcel Kool, Cynthia Hawkins, Charles G Eberhart, Adrian Dubuc, Toumy Guettouche, Yoslayma Cardentey,[...]. Acta Neuropathol 2012
243
17

Adult medulloblastoma comprises three major molecular variants.
Marc Remke, Thomas Hielscher, Paul A Northcott, Hendrik Witt, Marina Ryzhova, Andrea Wittmann, Axel Benner, Andreas von Deimling, Wolfram Scheurlen, Arie Perry,[...]. J Clin Oncol 2011
165
17

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.
Stefan Rutkowski, Katja von Hoff, Angela Emser, Isabella Zwiener, Torsten Pietsch, Dominique Figarella-Branger, Felice Giangaspero, David W Ellison, Maria-Luisa Garre, Veronica Biassoni,[...]. J Clin Oncol 2010
175
17

MRI surrogates for molecular subgroups of medulloblastoma.
S Perreault, V Ramaswamy, A S Achrol, K Chao, T T Liu, D Shih, M Remke, S Schubert, E Bouffet, P G Fisher,[...]. AJNR Am J Neuroradiol 2014
142
17

Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
Sarah Fattet, Christine Haberler, Patricia Legoix, Pascale Varlet, Arielle Lellouch-Tubiana, Severine Lair, Elodie Manie, Marie-Anne Raquin, Danielle Bours, Sabrina Carpentier,[...]. J Pathol 2009
144
16

BET bromodomain inhibition of MYC-amplified medulloblastoma.
Pratiti Bandopadhayay, Guillaume Bergthold, Brian Nguyen, Simone Schubert, Sharareh Gholamin, Yujie Tang, Sara Bolin, Steven E Schumacher, Rhamy Zeid, Sabran Masoud,[...]. Clin Cancer Res 2014
218
16

HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.
Yanxin Pei, Kun-Wei Liu, Jun Wang, Alexandra Garancher, Ran Tao, Lourdes A Esparza, Donna L Maier, Yoko T Udaka, Najiba Murad, Sorana Morrissy,[...]. Cancer Cell 2016
138
16

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.
Steven C Clifford, Birgitta Lannering, Ed C Schwalbe, Debbie Hicks, Kieran O'Toole, Sarah Leigh Nicholson, Tobias Goschzik, Anja Zur Mühlen, Dominique Figarella-Branger, François Doz,[...]. Oncotarget 2015
35
45

Active medulloblastoma enhancers reveal subgroup-specific cellular origins.
Charles Y Lin, Serap Erkek, Yiai Tong, Linlin Yin, Alexander J Federation, Marc Zapatka, Parthiv Haldipur, Daisuke Kawauchi, Thomas Risch, Hans-Jörg Warnatz,[...]. Nature 2016
214
16

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Paul A Northcott, Catherine Lee, Thomas Zichner, Adrian M Stütz, Serap Erkek, Daisuke Kawauchi, David J H Shih, Volker Hovestadt, Marc Zapatka, Dominik Sturm,[...]. Nature 2014
341
15

An animal model of MYC-driven medulloblastoma.
Yanxin Pei, Colin E Moore, Jun Wang, Alok K Tewari, Alexey Eroshkin, Yoon-Jae Cho, Hendrik Witt, Andrey Korshunov, Tracy-Ann Read, Julia L Sun,[...]. Cancer Cell 2012
198
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.